Melbourne Heart Rhythm has an international reputation as one of the centers of excellence in cardiac arrhythmia research in Australasia and indeed the world.

We have published broadly in the field of cardiac electrophysiology and have become one of the world leaders in the mechanisms of atrial arrhythmias and atrial fibrillation research. Below is a list of our recent publications:

  1. Bagnall RD, Molloy LK, Kalman JM et al. Exome sequencing identifies a mutation in the ACTN2 gene in a family with idiopathic ventricular fibrillation, left ventricular noncompaction, and sudden death. BMC Med Genet. 2014;15:99.
  2. Lau DH, Kalman J, Sanders P. Management of Recent-onset Sustained Atrial Fibrillation: Pharmacologic and Nonpharmacologic Strategies. Clin Ther. 2014;36(9):1151-1159.
  3. Pedersen CT, Kay GN, Kalman J et al. EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace. 2014;16:1257-1283.
  4. Ling LH, McLellan AJ, Taylor AJ et al. Magnetic resonance post-contrast T1 mapping in the human atrium: validation and impact on clinical outcome after catheter ablation for atrial fibrillation. Heart Rhythm. 2014;11:1551-1559.
  5. Brosnan M, Gerche AL, Kumar S et al. Modest Agreement in ECG Interpretation Limits the Application of ECG Screening in Young Athletes. Heart Rhythm. 2014
  6. Walters TE, Teh AW, Spence S et al. Absence of gender-based differences in the atrial and pulmonary vein substrate: a detailed electroanatomic mapping study. J Cardiovasc Electrophysiol. 2014;25:1065-1070.
  7. Kumar S, Sharma R, Kalman JM. Unmasking of familial long QT syndrome type 2 with crystal methamphetamine exposure. Heart Rhythm. 2014;11:1836-1838.
  8. Pedersen CT, Kay GN, Kalman J et al. EHRA/HRS/APHRS Expert Consensus on Ventricular Arrhythmias. Heart Rhythm. 2014;11:e166-96.
  9. Wyse DG, Van Gelder IC, Ellinor PT et al. Lone atrial fibrillation: does it exist? J Am Coll Cardiol. 2014;63:1715-1723.
  10. Kalman JM, Kistler PM, Taylor AJ. Cardiac magnetic resonance imaging to detect non-contiguous scar following atrial fibrillation ablation: identifying our knowledge gaps. Eur Heart J. 2014;35:1436-1438.
  11. Lee G, Kumar S, Teh A et al. Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activity. Eur Heart J. 2014;35:86-97.
  12. McLellan AJ, Ling LH, Azzopardi S et al. Diffuse Ventricular Fibrosis Measured by T1 Mapping on Cardiac MRI Predicts Success of Catheter Ablation for Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2014
  13. Walters TE, Kalman JM. Development of atrial fibrillation after atrial flutter ablation: more a question of when than whether. J Cardiovasc Electrophysiol 2014;25:821-823.
  14. Walters TE, Teh AW, Spence S et al. Relationship between the electrocardiographic atrial fibrillation cycle length and left atrial remodeling: a detailed electroanatomic mapping study. Heart Rhythm 2014;11:670-676.
  15. McLellan AJ, Ling LH, Ruggiero D et al. Pulmonary vein isolation: the impact of pulmonary venous anatomy on long-term outcome of catheter ablation for paroxysmal atrial fibrillation. Heart Rhythm 2014;11:549-556.
  16. Kumar S, Kalman JM. Catheter ablation for atrial fibrillation in the real world--insights from the J-CARAF registry. Circ J. 2014;78:1055-1057.
  17. Morris GM, Kalman JM. Fibrosis, electrics and genetics. Perspectives in sinoatrial node disease. Circ J. 2014;78:1272-1282.
  18. Kumar S, Chan M, Lee J et al. Catheter-Tissue Contact Force Determines Atrial Electrogram Characteristics Before and Lesion Efficacy After Antral Pulmonary Vein Isolation in Humans. J Cardiovasc Electrophysiol. 2013
  19. Shetty AK, Kalman JM. Concealed atrial ectopic focus originating from the tricuspid annulus. J Cardiovasc Electrophysiol. 2013;24:1054.
  20. Ling LH, Taylor AJ, Ellims AH et al. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. Heart Rhythm. 2013;10:1334-1339.
  21. Kumar S, Sutherland F, Stevenson I et al. Effects of long-term omega-3 polyunsaturated fatty acid supplementation on paroxysmal atrial tachyarrhythmia burden in patients with implanted pacemakers: results from a prospective randomised study. Int J Cardiol. 2013;168:3812-3817.
  22. Kumar S, Sutherland F, Lee JM et al. Effects of high dose intravenous fish oil on human atrial electrophysiology: implications for possible anti- and pro-arrhythmic mechanisms in atrial fibrillation. Int J Cardiol. 2013;168:2754-2760.
  23. Brooks AG, Wilson L, Chia NH et al. Accuracy and clinical outcomes of CT image integration with Carto-Sound compared to electro-anatomical mapping for atrial fibrillation ablation: a randomized controlled study. Int J Cardiol. 2013;168:2774-2782.
  24. Priori SG, Wilde AA, Horie M et al. Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Europace. 2013;15:1389-1406.
  25. Amerena JV, Walters TE, Mirzaee S et al. Update on the management of atrial fibrillation. Med J Aust. 2013;199:592-597.
  26. Abed HS, Wittert GA, Leong DP et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013;310:2050-2060.
  27. Kumar S, Peters S, Thompson T et al. Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes. Heart Rhythm. 2013;10:1653-1660.
  28. Haqqani HM, Morton JB, Kalman JM. Channeling post-infarction ventricular tachycardia ablation: "electroanatomy" versus electrophysiology. J Am Coll Cardiol. 2013;61:2096-2097.
  29. Kumar S, Haqqani HM, Chan M et al. Predictive value of impedance changes for real-time contact force measurements during catheter ablation of atrial arrhythmias in humans. Heart Rhythm. 2013;10:962-969.
  30. McLellan AJ, Kumar S, Smith C et al. The role of adenosine following pulmonary vein isolation in patients undergoing catheter ablation for atrial fibrillation: a systematic review. J Cardiovasc Electrophysiol. 2013;24:742-751.
  31. Kalman JM, Sanders P, Brieger DB et al. National Heart Foundation of Australia consensus statement on catheter ablation as a therapy for atrial fibrillation. Med J Aust. 2013;198:27-28.
  32. Abed HS, Samuel CS, Lau DH et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10:90-100.
  33. Lim HS, Willoughby SR, Schultz C et al. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol. 2013;61:852-860.
  34. Ganesan AN, Kuklik P, Lau DH et al. Bipolar electrogram shannon entropy at sites of rotational activation: implications for ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2013;6:48-57.
  35. Lee JM, Kalman JM. Sinus node dysfunction and atrial fibrillation: two sides of the same coin? Europace. 2013;15:161-162.
  36. Kumar S, Walters TE, Halloran K et al. Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia. Europace. 2013;15:1702-1709.
  37. Morris GM, Kalman JM, Boyett MR. Letter by Morris et al regarding article, "Low heart rates predict incident atrial fibrillation in healthy middle-aged men" by Grundvold et al. Circ Arrhythm Electrophysiol. 2013;6:e101.
  38. Wong MC, Edwards G, Spence SJ et al. Characterization of catheter-tissue contact force during epicardial radiofrequency ablation in an ovine model. Circ Arrhythm Electrophysiol. 2013;6:1222-1228.
  39. Medi C, Evered L, Silbert B et al. Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation. J Am Coll Cardiol. 2013;62:531-539.
  40. Ling LH, Kalman JM, Ellims AH et al. Diffuse ventricular fibrosis is a late outcome of tachycardia-mediated cardiomyopathy after successful ablation. Circ Arrhythm Electrophysiol. 2013;6:697-704.
  41. Wong MC, Kalman JM, Ling LH et al. Left septal atrial tachycardias: electrocardiographic and electrophysiologic characterization of a paraseptal focus. J Cardiovasc Electrophysiol. 2013;24:413-418.
  42. Lau DH, Middeldorp ME, Brooks AG et al. Aortic stiffness in lone atrial fibrillation: a novel risk factor for arrhythmia recurrence. PLoS One. 2013;8:e76776.
  43. Kumar S, Teh AW, Medi C et al. Atrial remodeling in varying clinical substrates within beating human hearts: relevance to atrial fibrillation. Prog Biophys Mol Biol. 2012;110:278-294.
  44. Kalman JM, Kumar S, Sanders P. Markers of collagen synthesis, atrial fibrosis, and the mechanisms underlying atrial fibrillation. J Am Coll Cardiol. 2012;60:1807-1808.
  45. Lee G, Sanders P, Kalman JM. Catheter ablation of atrial arrhythmias: state of the art. Lancet. 2012;380:1509-1519.
  46. Medi C, Teh AW, Roberts-Thomson K et al. Right atrial remodeling is more advanced in patients with atrial flutter than with atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23:1067-1072.
  47. Walters TE, Kistler PM, Morton JB et al. Impact of collimation on radiation exposure during interventional electrophysiology. Europace. 2012;14:1670-1673.
  48. Calkins H, Kuck KH, Cappato R et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. J Interv Card Electrophysiol. 2012;33:171-257.
  49. Dimitri H, Ng M, Brooks AG et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm. 2012;9:321-327.
  50. Teh AW, Kistler PM, Lee G et al. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease. J Cardiovasc Electrophysiol. 2012;23:232-238.
  51. Kumar S, Kalman JM, Sutherland F et al. Atrial fibrillation inducibility in the absence of structural heart disease or clinical atrial fibrillation: critical dependence on induction protocol, inducibility definition, and number of inductions. Circ Arrhythm Electrophysiol. 2012;5:531-536.
  52. Walters TE, Kistler PM, Kalman JM. Radiofrequency ablation for atrial tachycardia and atrial flutter. Heart Lung Circ. 2012;21:386-394.
  53. Adler A, van der Werf C, Postema PG et al. The phenomenon of "QT stunning": the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome. Heart Rhythm. 2012;9:901-908.
  54. Medi C, Kalman JM, Ling LH et al. Atrial electrical and structural remodeling associated with longstanding pulmonary hypertension and right ventricular hypertrophy in humans. J Cardiovasc Electrophysiol. 2012;23:614-620.
  55. Kumar S, Morton JB, Halloran K et al. Effect of respiration on catheter-tissue contact force during ablation of atrial arrhythmias. Heart Rhythm. 2012;9:1041-1047.e1.
  56. Teh AW, Kalman JM, Lee G et al. Electroanatomic remodelling of the pulmonary veins associated with age. Europace. 2012;14:46-51.
  57. Ganesan AN, Brooks AG, Roberts-Thomson KC et al. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol. 2012;59:719-726.
  58. Kalman JM, Sanders P. Introduction of new atrial fibrillation ablation technology into clinical practice: the cart before the horse? Heart Rhythm. 2012;9:297-298.
  59. Lee G, Spence S, Teh A et al. High-density epicardial mapping of the pulmonary vein-left atrial junction in humans: insights into mechanisms of pulmonary vein arrhythmogenesis. Heart Rhythm. 2012;9:258-264.
  60. Ling LH, Kistler PM, Ellims AH et al. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. J Am Coll Cardiol. 2012;60:2402-2408.
  61. Kumar S, Morton JB, Lee J et al. Prospective characterization of catheter-tissue contact force at different anatomic sites during antral pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2012;5:1124-1129.
  62. Kumar S, Ling LH, Halloran K et al. Esophageal hematoma after atrial fibrillation ablation: incidence, clinical features, and sequelae of esophageal injury of a different sort. Circ Arrhythm Electrophysiol. 2012;5:701-705.
  63. Kalman JM, Joseph SA. Simulation and clinical training: the future and the indispensable past. Heart Rhythm. 2012;9:1286-1287.
  64. Mahajan R, Brooks AG, Sullivan T et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart. 2012;98:1120-1126.
  65. Robinson T, Kalman JM. Proarrhythmia following prior pulmonary vein isolation: what is the mechanism? J Cardiovasc Electrophysiol. 2012;23:884-886.
  66. Calkins H, Kuck KH, Cappato R et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14:528-606.
  67. Calkins H, Kuck KH, Cappato R et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society. Heart Rhythm. 2012;9:632-696.e21.
  68. Teh AW, Kistler PM, Lee G et al. Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm. 2012;9:473-480.
  69. Kumar S, Sutherland F, Morton JB et al. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion. Heart Rhythm. 2012;9:483-491.
  70. Teh AW, Kistler PM, Lee G et al. Electroanatomic properties of the pulmonary veins: slowed conduction, low voltage and altered refractoriness in AF patients. J Cardiovasc Electrophysiol. 2011;22:1083-1091.
  71. Lee G, Roberts-Thomson K, Madry A et al. Relationship among complex signals, short cycle length activity, and dominant frequency in patients with long-lasting persistent AF: a high-density epicardial mapping study in humans. Heart Rhythm. 2011;8:1714-1719.
  72. Lee G, Sparks PB, Morton JB et al. Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center. J Cardiovasc Electrophysiol. 2011;22:163-168.
  73. Cappato R, Calkins H, Chen SA et al. Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report. J Am Coll Cardiol. 2011;58:2696-2697.
  74. Medi C, Kalman JM, Spence SJ et al. Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation. J Cardiovasc Electrophysiol. 2011;22:1317-1324.
  75. Teh AW, Kistler PM, Lee G et al. The relationship between complex fractionated electrograms and atrial low-voltage zones during atrial fibrillation and paced rhythm. Europace. 2011;13:1709-1716.
  76. Kumar S, Sutherland F, Teh AW et al. Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human pulmonary vein and left atrial electrophysiology in paroxysmal atrial fibrillation. Am J Cardiol. 2011;108:531-535.
  77. Feldman A, Voskoboinik A, Kumar S et al. Predictors of acute and long-term success of slow pathway ablation for atrioventricular nodal reentrant tachycardia: a single center series of 1,419 consecutive patients. Pacing Clin Electrophysiol. 2011;34:927-933.
  78. Lee G, Kalman JM, Vohra JK et al. Dissociated pulmonary vein potentials following antral pulmonary vein isolation for atrial fibrillation: impact on long-term outcome. Heart. 2011;97:579-584.
  79. Teh AW, Medi C, Lee G et al. Long-term outcome following ablation of atrial flutter occurring late after atrial septal defect repair. Pacing Clin Electrophysiol. 2011;34:431-435.
  80. Kumar S, Sutherland F, Rosso R et al. Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human atrial electrophysiology. Heart Rhythm. 2011;8:562-568.
  81. Tu HT, Campbell BC, Churilov L et al. Frequent early cardiac complications contribute to worse stroke outcome in atrial fibrillation. Cerebrovasc Dis. 2011;32:454-460.
  82. Teh AW, Kalman JM, Kistler PM et al. Prevalence of fractionated electrograms in the coronary sinus: comparison between patients with persistent or paroxysmal atrial fibrillation and a control population. Heart Rhythm. 2010;7:1200-1204.
  83. Stevenson IH, Roberts-Thomson KC, Kistler PM et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm. 2010;7:1263-1270.
  84. Lee G, Wu H, Kalman JM et al. Atrial fibrillation following lung transplantation: double but not single lung transplant is associated with long-term freedom from paroxysmal atrial fibrillation. Eur Heart J. 2010;31:2774-2782.
  85. Viskin S, Postema PG, Bhuiyan ZA et al. The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol. 2010;55:1955-1961.
  86. Snowdon RL, Balasubramaniam R, Teh AW et al. Linear ablation of right atrial free wall flutter: demonstration of bidirectional conduction block as an endpoint associated with long-term success. J Cardiovasc Electrophysiol. 2010;21:526-531.
  87. Teh AW, Lee G, Kalman JM. A case of focal atrial tachycardia from the aortomitral continuity. J Cardiovasc Electrophysiol. 2010;21:583-584.
  88. Rosso R, Sparks PB, Morton JB et al. Vagal paroxysmal atrial fibrillation: prevalence and ablation outcome in patients without structural heart disease. J Cardiovasc Electrophysiol. 2010;21:489-493.
  89. Stiles MK, Brooks AG, Roberts-Thomson KC et al. High-density mapping of the sinus node in humans: role of preferential pathways and the effect of remodeling. J Cardiovasc Electrophysiol. 2010;21:532-539.
  90. John B, Stiles MK, Kuklik P et al. Reverse remodeling of the atria after treatment of chronic stretch in humans: implications for the atrial fibrillation substrate. J Am Coll Cardiol. 2010;55:1217-1226.
  91. Kalman JM, Teh AW. Ablation of complex fractionated electrograms in persistent atrial fibrillation: have we reached the endpoint? Heart Rhythm. 2010;7:303-304.
  92. Heck PM, Kalman JM. Atrial tachycardia originating from the pulmonary vein: focus on mapping or zapping? Pacing Clin Electrophysiol. 2010;33:773-775.
  93. Teh AW, Kalman JM, Medi C et al. Long-term outcome following successful catheter ablation of atrial tachycardia originating from the pulmonary veins: absence of late atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21:747-750.
  94. Cappato R, Calkins H, Chen SA et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3:32-38.
  95. Rosso R, Morton JB, Aggarwal A et al. Image integration to guide ablation of incessant left atrial appendage tachycardia. Heart Rhythm. 2010;7:1913-1914.
  96. Lee G, Kalman JM. Endpoints in ablation of paroxysmal atrial fibrillation: when is enough enough? J Cardiovasc Electrophysiol. 2010;21:389-392.
  97. Cappato R, Calkins H, Chen SA et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2009;53:1798-1803.
  98. Medi C, Kalman JM, Haqqani H et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. J Am Coll Cardiol. 2009;53:1791-1797.
  99. Roberts-Thomson KC, Kistler PM, Sanders P et al. Fractionated atrial electrograms during sinus rhythm: relationship to age, voltage, and conduction velocity. Heart Rhythm. 2009;6:587-591.
  100. Medi C, Kalman JM, Freedman SB. Supraventricular tachycardia. Med J Aust. 2009;190:255-260.
  101. Teh AW, Kistler PM, Kalman JM. Using the 12-lead ECG to localize the origin of ventricular and atrial tachycardias: part 1. Focal atrial tachycardia. J Cardiovasc Electrophysiol. 2009;20:706-9; quiz 705.
  102. Haqqani HM, Kalman JM, Roberts-Thomson KC et al. Fundamental differences in electrophysiologic and electroanatomic substrate between ischemic cardiomyopathy patients with and without clinical ventricular tachycardia. J Am Coll Cardiol. 2009;54:166-173.
  103. Roberts-Thomson KC, John B, Worthley SG et al. Left atrial remodeling in patients with atrial septal defects. Heart Rhythm. 2009;6:1000-1006.
  104. Haqqani HM, Morton JB, Kalman JM. Using the 12-lead ECG to localize the origin of atrial and ventricular tachycardias: part 2--ventricular tachycardia. J Cardiovasc Electrophysiol. 2009;20:825-832.
  105. Roberts-Thomson KC, Stevenson I, Kistler PM et al. The role of chronic atrial stretch and atrial fibrillation on posterior left atrial wall conduction. Heart Rhythm. 2009;6:1109-1117.
  106. John B, Stiles MK, Kuklik P et al. Electrical remodelling of the left and right atria due to rheumatic mitral stenosis. Eur Heart J. 2008;29:2234-2243.
  107. Haqqani HM, Kalman JM, Kistler PM. Catheter ablation for atrial fibrillation: have we come the full circle? J Cardiovasc Electrophysiol. 2008;19:480-482.
  108. Stevenson IH, Teichtahl H, Cunnington D et al. Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function. Eur Heart J. 2008;29:1662-1669.
  109. Medi C, Kalman JM. Prediction of the atrial flutter circuit location from the surface electrocardiogram. Europace. 2008;10:786-796.
  110. Roberts-Thomson KC, Stevenson IH, Kistler PM et al. Anatomically determined functional conduction delay in the posterior left atrium relationship to structural heart disease. J Am Coll Cardiol. 2008;51:856-862.
  111. Snowdon RL, Balasubramaniam R, Haqqani H et al. Upper loop reentry post mitral valve repair. J Cardiovasc Electrophysiol. 2008;19:1325-1326.
  112. Rosso R, Kalman JM, Rogowski O et al. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2007;4:1149-1154.
  113. Haqqani HM, Kalman JM. Aging and sinoatrial node dysfunction: musings on the not-so-funny side. Circulation. 2007;115:1178-1179.
  114. Kalman JM, Kistler PM, Waldo AL. Localization of focal atrial tachycardias--back to the future.when (old) electrophysiologic first principles complement sophisticated technology. J Cardiovasc Electrophysiol. 2007;18:7-8.
  115. Roberts-Thomson KC, Kalman JM. Right septal macroreentrant tachycardia late after mitral valve repair: Importance of surgical access approach. Heart Rhythm. 2007;4:32-36.
  116. Roberts-Thomson KC, Sanders P, Kalman JM. Sinus node disease: an idiopathic right atrial myopathy. Trends Cardiovasc Med. 2007;17:211-214.
  117. Hillock RJ, Kalman JM, Roberts-Thomson KC et al. Multiple focal atrial tachycardias in a healthy adult population: characterization and description of successful radiofrequency ablation. Heart Rhythm. 2007;4:435-438.
  118. Roberts-Thomson KC, Kistler PM, Haqqani HM et al. Focal atrial tachycardias arising from the right atrial appendage: electrocardiographic and electrophysiologic characteristics and radiofrequency ablation. J Cardiovasc Electrophysiol. 2007;18:367-372.
  119. Kistler PM, Roberts-Thomson KC, Haqqani HM et al. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. J Am Coll Cardiol. 2006;48:1010-1017.
  120. Sanders P, Kalman JM. Progressive and persistent atrial inexcitability. Pacing Clin Electrophysiol. 2006;29:546-548.
  121. Roberts-Thomson KC, Kistler PM, Kalman JM. Focal atrial tachycardia I: clinical features, diagnosis, mechanisms, and anatomic location. Pacing Clin Electrophysiol. 2006;29:643-652.
  122. Roberts-Thomson KC, Kistler PM, Kalman JM. Focal atrial tachycardia II: management. Pacing Clin Electrophysiol. 2006;29:769-778.
  123. Kistler PM, Sanders P, Dodic M et al. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation. Eur Heart J. 2006;27:3045-3056.
  124. Hillock RJ, Singarayar S, Kalman JM et al. Tale of two tails: the tip of the atrial appendages is an unusual site for focal atrial tachycardia. Heart Rhythm. 2006;3:467-469.
  125. Haqqani HM, Kalman JM. Recently diagnosed nonischemic dilated cardiomyopathy: when should we implant the defibrillator? Heart Rhythm. 2006;3:404-405.
  126. Kistler PM, Kalman JM, Fynn SP et al. Rapid decline in acute stimulation thresholds with steroid-eluting active-fixation pacing leads. Pacing Clin Electrophysiol. 2005;28:903-909.
  127. Roberts-Thomson KC, Kistler PM, Kalman JM. Atrial tachycardia: mechanisms, diagnosis, and management. Curr Probl Cardiol. 2005;30:529-573.
  128. Badhwar N, Kalman JM, Sparks PB et al. Atrial tachycardia arising from the coronary sinus musculature: electrophysiological characteristics and long-term outcomes of radiofrequency ablation. J Am Coll Cardiol. 2005;46:1921-1930.
  129. Kistler PM, Fynn SP, Haqqani H et al. Focal atrial tachycardia from the ostium of the coronary sinus: electrocardiographic and electrophysiological characterization and radiofrequency ablation. J Am Coll Cardiol. 2005;45:1488-1493.
  130. Kistler PM, Kalman JM. Locating focal atrial tachycardias from P-wave morphology. Heart Rhythm. 2005;2:561-564.
  131. Cappato R, Calkins H, Chen SA et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111:1100-1105.
  132. Stevenson IH, Kistler PM, Spence SJ et al. Scar-related right atrial macroreentrant tachycardia in patients without prior atrial surgery: electroanatomic characterization and ablation outcome. Heart Rhythm. 2005;2:594-601.
  133. Viskin S, Rosovski U, Sands AJ et al. Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one. Heart Rhythm. 2005;2:569-574.
  134. Kistler PM, Davidson NC, Sanders P et al. Absence of acute effects of angiotensin II on atrial electrophysiology in humans. J Am Coll Cardiol. 2005;45:154-156.
  135. Morton JB, Kalman JM. Intracardiac echocardiographic anatomy for the interventional electrophysiologist. J Interv Card Electrophysiol. 2005;13 Suppl 1:11-16.
  136. Fynn SP, Kalman JM. Pulmonary veins: anatomy, electrophysiology, tachycardia, and fibrillation. Pacing Clin Electrophysiol. 2004;27:1547-1559.
  137. Morton JB, Sanders P, Kalman JM. Catheter ablation of atrial fibrillation: raising expectations for patients and physicians. Heart Rhythm. 2004;1:40-42.
  138. Kistler PM, Kalman JM, Fynn SP et al. Irregular tachycardia with varying degrees of bundle branch block aberration: what is the mechanism? J Cardiovasc Electrophysiol. 2004;15:611-613.
  139. Sanders P, Morton JB, Kistler PM et al. Electrophysiological and electroanatomic characterization of the atria in sinus node disease: evidence of diffuse atrial remodeling. Circulation. 2004;109:1514-1522.
  140. Fynn SP, Kalman JM. Bundle branch reentrant tachycardia in a patient with normal ventricular function. J Interv Card Electrophysiol. 2004;10:255-259.
  141. Kistler PM, Sanders P, Fynn SP et al. Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Cardiol. 2004;44:109-116.
  142. Stevenson I, Kalman J. Magnetic resonance imaging in the diagnosis of arrhythmogenic right ventricular cardiomyopathy: the gold standard or just another imaging modality? J Interv Card Electrophysiol. 2004;10:27-29.
  143. Singarayar S, Kalman JM. Focal atrial tachycardia: is it yet time for a new paradigm? J Cardiovasc Electrophysiol. 2004;15:1394-1395.
  144. Sanders P, Kistler PM, Morton JB et al. Remodeling of sinus node function in patients with congestive heart failure: reduction in sinus node reserve. Circulation. 2004;110:897-903.
  145. Kistler PM, Sanders P, Morton JB et al. Effect of body mass index on defibrillation thresholds for internal cardioversion in patients with atrial fibrillation. Am J Cardiol. 2004;94:370-372.
  146. Fynn SP, Morton JB, Deen VR et al. Conduction characteristics at the crista terminalis during onset of pulmonary vein atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15:855-861.
  147. Sanders P, Morton JB, Davidson NC et al. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation. 2003;108:1461-1468.
  148. Sanders P, Morton JB, Kistler PM et al. Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy. Circulation. 2003;108:1976-1984.
  149. Kistler PM, Sanders P, Fynn SP et al. Electrophysiological and electrocardiographic characteristics of focal atrial tachycardia originating from the pulmonary veins: acute and long-term outcomes of radiofrequency ablation. Circulation. 2003;108:1968-1975.
  150. Kistler PM, Sanders P, Hussin A et al. Focal atrial tachycardia arising from the mitral annulus: electrocardiographic and electrophysiologic characterization. J Am Coll Cardiol. 2003;41:2212-2219.
  151. Morton JB, Sanders P, Davidson NC et al. Phased-array intracardiac echocardiography for defining cavotricuspid isthmus anatomy during radiofrequency ablation of typical atrial flutter. J Cardiovasc Electrophysiol. 2003;14:591-597.
  152. Morton JB, Sanders P, Vohra JK et al. Effect of chronic right atrial stretch on atrial electrical remodeling in patients with an atrial septal defect. Circulation. 2003;107:1775-1782.
  153. Hussin A, Sanders P, Kistler PM et al. Accessory pathway in left inferoposterior diverticulum masquerading as left posterior pathway due to conduction over coronary sinus to left atrium connection. J Cardiovasc Electrophysiol. 2003;14:403-406.
  154. Sanders P, Morton JB, Morgan JG et al. Reversal of atrial mechanical stunning after cardioversion of atrial arrhythmias: implications for the mechanisms of tachycardia-mediated atrial cardiomyopathy. Circulation. 2002;106:1806-1813.
  155. Morton JB, Sanders P, Sparks PB et al. Usefulness of phased-array intracardiac echocardiography for the assessment of left atrial mechanical "stunning" in atrial flutter and comparison with multiplane transesophageal echocardiography(*). Am J Cardiol. 2002;90:741-746.
  156. Morton JB, Sanders P, Deen V et al. Sensitivity and specificity of concealed entrainment for the identification of a critical isthmus in the atrium: relationship to rate, anatomic location and antidromic penetration. J Am Coll Cardiol. 2002;39:896-906.
  157. Morton JB, Byrne MJ, Power JM et al. Electrical remodeling of the atrium in an anatomic model of atrial flutter: relationship between substrate and triggers for conversion to atrial fibrillation. Circulation. 2002;105:258-264.
  158. Davidson NC, Morton JB, Sanders P et al. Latent Mahaim fiber as a cause of antidromic reciprocating tachycardia: recognition and successful radiofrequency ablation. J Cardiovasc Electrophysiol. 2002;13:74-78.
  159. Deen VR, Morton JB, Vohra JK et al. Pulmonary vein paced activation sequence mapping: comparison with activation sequences during onset of focal atrial fibrillation. J Cardiovasc Electrophysiol. 2002;13:101-107.

our-research1

Our Research

Melbourne Heart Rhythm has an international reputation as one of the centers of excellence in cardiac arrhythmia research in Australasia and the world.

Read more

our-team

Our Team

Our friendly team are committed to providing excellence in patient care. They are all well qualified and knowledgeable about patients and their cardiac conditions.

Read more

media-library

Learn More

To learn about common arrhythmias and our cardiac procedures, visit  our Cardiovascular Library for more information.

Read more

About Us


rmhandmphnew

Melbourne Heart Rhythm is the arrhythmia service at the Department of Cardiology at the Royal Melbourne Hospital. We are comprised of a team of highly trained and dedicated health care professionals specializing in heart rhythm management. We have a strong focus on patient education and patient centered care. Our arrhythmia specialists have an international reputation of excellence in arrhythmia research and clinical arrhythmia management.